Moberg Pharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Anna Ljung

Chief executive officer

kr3.5m

Total compensation

CEO salary percentage56.6%
CEO tenure5yrs
CEO ownership0.03%
Management average tenure4.6yrs
Board average tenure2yrs

Recent management updates

Recent updates

Moberg Pharma (STO:MOB) Will Have To Spend Its Cash Wisely

Nov 16
Moberg Pharma (STO:MOB) Will Have To Spend Its Cash Wisely

Will Moberg Pharma (STO:MOB) Spend Its Cash Wisely?

Jan 17
Will Moberg Pharma (STO:MOB) Spend Its Cash Wisely?

Read This Before Selling Moberg Pharma AB (publ) (STO:MOB) Shares

Dec 03
Read This Before Selling Moberg Pharma AB (publ) (STO:MOB) Shares

CEO Compensation Analysis

How has Anna Ljung's remuneration changed compared to Moberg Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023kr4mkr2m

-kr21m

Sep 30 2023n/an/a

-kr18m

Jun 30 2023n/an/a

-kr16m

Mar 31 2023n/an/a

-kr16m

Dec 31 2022kr3mkr2m

-kr16m

Sep 30 2022n/an/a

-kr17m

Jun 30 2022n/an/a

-kr16m

Mar 31 2022n/an/a

-kr16m

Dec 31 2021kr2mkr1m

-kr16m

Sep 30 2021n/an/a

kr8m

Jun 30 2021n/an/a

kr7m

Mar 31 2021n/an/a

kr5m

Dec 31 2020kr3mkr2m

kr7m

Jun 30 2020n/an/a

kr20m

Jun 30 2019kr476kkr151k

-kr8m

Compensation vs Market: Anna's total compensation ($USD324.62K) is about average for companies of similar size in the Swedish market ($USD252.27K).

Compensation vs Earnings: Anna's compensation has increased whilst the company is unprofitable.


CEO

Anna Ljung (43 yo)

5yrs

Tenure

kr3,511,000

Compensation

Ms. Anna Ljung, M.Sc. Econ., BA served as Chairman of The Board at OncoZenge AB (publ) until August 2023. She joined company since 2020. Ms. Ljung has been Director at Saniona AB (publ) since January 19, 2...


Leadership Team

NamePositionTenureCompensationOwnership
Anna Ljung
Chief Executive Officer5yrskr3.51m0.026%
SEK 269.9k
Marie Moberg
Co-Founder18.2yrskr193.70kno data
Mark Beveridge
Vice President of Finance4.6yrsno data0.056%
SEK 568.4k
Christina Erixon
Head of Pharmaceutical Development & Operationsless than a yearno datano data
Gunilla Wengström
Senior Director of Sales & Marketing5.3yrsno datano data
Anders Broijersen
Chief Medical Officer1.5yrsno data0.000030%
SEK 306.8
Robert Ehrl
Head of Supplyless than a yearno datano data

4.6yrs

Average Tenure

53yo

Average Age

Experienced Management: MOB's management team is considered experienced (4.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Howard Maibach
Member of Scientific Advisory Boardno datano datano data
Anders Lundmark
Independent Director2yrskr170.00k0.36%
SEK 3.7m
Hakan Wallin
Independent Directorless than a yearkr99.00kno data
Jan Faergemann
Member of Scientific Advisory Boardno datano datano data
Lennart Emtestam
Member of Scientific Advisory Boardno datano datano data
Johan Heilborn
Member of Scientific Advisory Boardno datano datano data
Bernt Lindelöf
Member of Scientific Advisory Boardno datano datano data
Kerstin Strinnholm
Independent Chairman of the Board2yrskr360.00k0.032%
SEK 329.0k
Nikolaj Sorensen
Independent Director3yrskr170.00k0.026%
SEK 264.2k

2.0yrs

Average Tenure

62yo

Average Age

Experienced Board: MOB's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.